Thank you, Mr. Chair.
I want to start by addressing some questions that previous witnesses have had over our last couple of meetings.
First, dealing with PIPEDA, Ms. Denham, it was suggested by one of the witnesses in the last meeting that PIPEDA was sufficient to address spamming activities.
I just want to find out whether you concur with this view.